Request Demo
Last update 04 Mar 2026
G.C. Chemie Pharmie Ltd.
Last update 04 Mar 2026
Overview
Related
CTRI/2025/09/094225
A double blind, balanced, randomized, two-treatment, two-sequence, two-period, single dose, crossover, pharmacokinetic and pharmacodynamic bioequivalence study of insulin degludec and insulin aspart injection 100 units/mL of G. C Chemie Pharmie Limited, India comparing with Ryzodeg (Insulin degludec/Insulin aspart) 100 units/mL of Novo Nordisk A/S, Novo All?, DK-2880 Bagsv?rd, Denmark, in healthy, adult, human male subjects using Euglycemic clamp technique under fasting conditions.
CTRI/2022/12/047860
A prospective, randomized, open-label, active-controlled, clinical study to evaluate the tolerability and incidence of pregnancy complications up on Lipocal supplementation in pregnant women
CTRI/2022/11/047443
A Randomized, Double-Blind, Multi-center, Phase III Study to Assess and Compare the Immunogenicity and Safety of the 13-valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13-TT) with PREVENAR 13® of Pfizer Inc. in Healthy Infants in India
100 Clinical Results associated with G.C. Chemie Pharmie Ltd.
Login to view more data
Login to view more data
100 Deals associated with G.C. Chemie Pharmie Ltd.
Login to view more data
100 Translational Medicine associated with G.C. Chemie Pharmie Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 18 Mar 2026
No data posted
Login to keep update
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free